HBI Deals+Insights / News
Swiss multinational pharmaceutical firm Novartis has agreed to acquire UK-based biotech Myricx Bio for up to $1.5 billion (~€1.31bn), including $1.1 billion (€963 million) cash upfront plus potential milestone payments.





